PRIMARY STUDY
Δ8-Tetrahydrocannabivarin Prevents Hepatic Ischaemia/Reperfusion Injury by Decreasing Oxidative Stress and Inflammatory Responses Through Cannabinoid CB2 Receptors
Key Findings: CB2 activation via Δ(8) -THCV (a synthetic analogue of the plant cannabinoid Δ(9) -THCV) activated decreased tissue injury and inflammation associated with ischaemia-reperfusion injury.
Type of Study: Animal Study
Study Result: Positive
Study Location(s): United States
Year of Pub: 2012
Cannabinoids Studied: Cannabinoid (unspecified), Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB2
Ligands Studied: Anti-inflammatory cytokines, Pro-inflammatory cytokines
